These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10190012)

  • 1. [Characteristics Ca2+-induced hyperpolarization in erythrocytes from patients with tumors of various localization].
    Petrova IV; Sokolova IB; Stepovaia EA; Kolosova MV; Koriukin VI; Gol'dberg VE; Baskakov MB; Medvedev MA; Novitskiĭ VV
    Biull Eksp Biol Med; 1999 Jan; 127(1):77-80. PubMed ID: 10190012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of Ca(2+)-induced response of erythrocytes in patients with lung cancer during antineoplastic chemotherapy].
    Petrova IV; Stepovaia EA; Sokolova IB; Gol'dberg VE; Chasovskikh NIu; Koreshkova KG; Bazhenova NG; Kolosova MV; Baskakov MB; Novitskiĭ VV; Medvedev MA
    Biull Eksp Biol Med; 1997 Aug; 124(8):195-8. PubMed ID: 9410209
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue polypeptide antigen in bronchogenic carcinoma.
    Zatloukal P; Glagolicová A; Linhart M; Sebes A; Hencl P; Mĕricka O
    Neoplasma; 1993; 40(5):301-3. PubMed ID: 8272159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elastase levels in small and non-small cell lung carcinoma.
    Güner G; Kirkali G; Baskin Y; Karlikaya C; Akkoçlu A
    Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):305S. PubMed ID: 8224451
    [No Abstract]   [Full Text] [Related]  

  • 5. Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancer.
    Gridelli C
    Curr Opin Oncol; 2009 Mar; 21(2):97-8. PubMed ID: 19532008
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical investigation of bronchioloalveolar carcinoma: a retrospective analysis of 53 patients in a single institution.
    Fujimoto N; Segawa Y; Takigawa N; Hotta K; Kishino D; Shimono M; Nakata M; Saeki H; Mandai K; Eguch K
    Anticancer Res; 1999; 19(2B):1369-73. PubMed ID: 10365108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Second primary lung cancer in laryngeal cancer patients: report on 36 cases].
    Gao Y; Wang L; Zhang D
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):341-3. PubMed ID: 11783123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible causes for an increased content of blood peptide hormones in small-cell lung cancer].
    Raĭkhlin NT; Smirnova EA; Blinova SA; Deĭneko GM; Bassalyk LS
    Vopr Onkol; 1989; 35(2):203-7. PubMed ID: 2564709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
    Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
    Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrokinetic potential of lung cancer cells.
    Oksiejczuk E; Figaszewski Z
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():340-5. PubMed ID: 9337551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYFRA 21-1 in the follow-up of inoperable non-small cell lung cancer patients treated with chemotherapy.
    Ebert W; Muley T
    Anticancer Res; 1999; 19(4A):2669-72. PubMed ID: 10470217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of the month: triple carcinomas in Cronkhite-Canada syndrome.
    Jpn J Clin Oncol; 1999 Jun; 29(6):inside front cover. PubMed ID: 10418554
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer.
    Gencer M; Ceylan E; Aksoy N; Uzun K
    Respiration; 2006; 73(4):520-4. PubMed ID: 16432293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on endothelin-1 positive expression and quantitative analysis in lung cancer].
    Yang X; Liu L; Qi H
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):111-3. PubMed ID: 11263384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of A549 carcinoma cell protein synthesis profile induced by lung cancer patient serum.
    Machado Paschoal ME; Da Glória Da Costa Carvalho M
    Int J Mol Med; 2001 Aug; 8(2):211-5. PubMed ID: 11445877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fatal massive pulmonary hemorrhage due to bronchial carcinoma].
    Haupt R
    Frankf Z Pathol; 1966; 75(5):412-8. PubMed ID: 16300334
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer].
    Li R; Li R; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma thymosin-alpha1 levels in lung cancer patients.
    Sasaki H; Fujii Y; Masaoka A; Yamakawa Y; Fukai I; Kiriyama M; Saito Y; Matsui H
    Eur J Cardiothorac Surg; 1997 Dec; 12(6):885-91. PubMed ID: 9489875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA.
    Beau-Faller M; Weber JC; Schneider A; Guèrin E; Gasser B; Ducrocq X; Jaeck D; Wihlm JM; Quoix E; Gaub MP
    Cancer; 2003 May; 97(9):2308-17. PubMed ID: 12712488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.